Allogeneic natural killer cell therapy

MM Berrien-Elliott, MT Jacobs, TA Fehniger - Blood, 2023 - ashpublications.org
Interest in adoptive cell therapy for treating cancer is exploding owing to early clinical
successes of autologous chimeric antigen receptor (CAR) T lymphocyte therapy. However …

The function of NK cells in tumor metastasis and NK cell-based immunotherapy

Y Yu - Cancers, 2023 - mdpi.com
Simple Summary Innate immune natural killer (NK) cells are capable of killing metastatic
cancer cells without activation by antigen-presenting cells beforehand. The cytotoxic effects …

Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression

MR Parkhurst, JP Riley, ME Dudley… - Clinical Cancer Research, 2011 - AACR
Purpose: Adoptive transfer of tumor-infiltrating lymphocytes (TIL) can mediate regression of
metastatic melanoma. However, many patients with cancer are ineligible for such treatment …

Expansion of highly cytotoxic human natural killer cells for cancer cell therapy

H Fujisaki, H Kakuda, N Shimasaki, C Imai, J Ma… - Cancer research, 2009 - AACR
Infusions of natural killer (NK) cells are an emerging tool for cancer immunotherapy. The
development of clinically applicable methods to produce large numbers of fully functional …

Overcoming resistance to natural killer cell based immunotherapies for solid tumors

G Nayyar, Y Chu, MS Cairo - Frontiers in oncology, 2019 - frontiersin.org
Despite advances in the diagnostic and therapeutic modalities, the prognosis of several
solid tumor malignancies remains poor. Different factors associated with solid tumors …

Activation, coactivation, and costimulation of resting human natural killer cells

YT Bryceson, ME March, HG Ljunggren… - Immunological …, 2006 - Wiley Online Library
Natural killer (NK) cells possess potent perforin‐and interferon‐γ‐dependent effector
functions that are tightly regulated. Inhibitory receptors for major histocompatibility complex …

[HTML][HTML] NK cell-based immunotherapies in cancer

MH Shin, J Kim, SA Lim, J Kim, SJ Kim, KM Lee - Immune network, 2020 - ncbi.nlm.nih.gov
With the development of technologies that can transform immune cells into therapeutic
modalities, immunotherapy has remarkably changed the current paradigm of cancer …

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

T Lakshmikanth, S Burke, TH Ali… - The Journal of …, 2009 - Am Soc Clin Investig
NK cells use a variety of receptors to detect abnormal cells, including tumors and their
metastases. However, in the case of melanoma, it remains to be determined what specific …

Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of …

D Pende, GM Spaggiari, S Marcenaro, S Martini… - Blood, 2005 - ashpublications.org
On the basis of recent clinical and experimental data, natural killer (NK) cells appear to play
a crucial role in eradication of acute myeloid leukemias. In the present study, by exploiting …

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against …

M Berg, A Lundqvist, P McCoy Jr, L Samsel, Y Fan… - …, 2009 - Taylor & Francis
Background aims Cancer immunotherapy involving natural killer (NK) cell infusions and
administration of therapeutic agents modulating the susceptibility of tumors to NK-cell lysis …